Abstract
To determine whether intravenous immunoglobulin (IVGG) would be an efficacious adjunct in the treatment of childhood minimal change nephrotic syndrome (MCNS), we enrolled ten patients with frequently relapsing or steroid-dependent MCNS in a double-blind crossover clinical trial. At the time of relapse of the nephrotic syndrome, patients were assigned to treatment with a single outpatient infusion of IVGG (800 mg/kg) or intravenous albumin as a control. The relapse was treated concurrently with standard doses of oral prednisone. At the time of the next relapse, patients who had first received IVGG were treated with albumin, and vice versa. There were no significant differences in the length of remission between the IVGG and albumin treatments. The study had a power of 0.72 to detect a true difference of 45 days between the two therapies. We conclude that in the dose of drug used in this trial, administered at the time of relapse in conjunction with prednisone therapy to children with frequently relapsing or steroid-dependent MCNS, IVGG does not lead to a clinically important extension of the period of remission.
Similar content being viewed by others
References
Giangiacomo J, Cleary TG, Cole BR, Hoffsten P, Robson AM (1975) Serum immunoglobulins in the nephrotic syndrome: a possible cause of minimal-change nephrotic syndrome. N Engl J Med 293: 8–12
Heslan JM, Lautie JP, Intrator L, Blanc C, Lagrue G, Sobel AT (1982) Impaired IgG synthesis in patients with the nephrotic syndrome. Clin Nephrol 18: 144–147
Levinsky RJ, Malleson PN, Barratt TM, Soothill JF (1978) Circulating immune complexes in steroid-responsive nephrotic syndrome. N Engl J Med 298: 126–129
International Study of Kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 98: 561–564
Ginsberg JM, Chang BS, Matarese RA, Garella S (1983) Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 309: 1543–1546
International Study of Kidney Disease in Children (1979) Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid responsive patients who relapse early. J Pediatr 95: 239–243
Lachin J (1981) Introduction to sample size determination and power analysis for clinical trials. Controlled Clin Trials 2: 93–113
Ross LD (1985) Proteins. In: Bishop ML, Duben-Von Laufen JL, Fody EP (eds) Clinical chemistry: principles, procedures, correlations. Lippincott, Philadelphia, p 196
Hudson H, Rappoport A (1968) Estimation of creatinine by the Jaffe reaction: a comparison of three methods. Clin Chem 14: 222–238
MacDonald NE, Wolfish N, McLaine P, Phipps P, Rossier E (1986) Role of respiratory viruses in exacerbations of primary nephrotic syndrome. J Pediatr 108: 378–382
Louis TA, Lavoie PW, Bailar JC, Polansky M (1984) Crossover and self-controlled designs in clinical research. N Engl J Med 310: 24–31
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rowe, P.C., McLean, R.H., Ruley, E.J. et al. Intravenous immunoglobulin in minimal change nephrotic syndrome: a crossover trial. Pediatr Nephrol 4, 32–35 (1990). https://doi.org/10.1007/BF00858434
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00858434